18-54224400-C-G
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The ENST00000256429.8(MBD2):āc.160G>Cā(p.Ala54Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000216 in 1,251,116 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000256429.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MBD2 | NM_003927.5 | c.160G>C | p.Ala54Pro | missense_variant | 1/7 | ENST00000256429.8 | NP_003918.1 | |
MBD2 | NM_015832.6 | c.160G>C | p.Ala54Pro | missense_variant | 1/3 | NP_056647.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MBD2 | ENST00000256429.8 | c.160G>C | p.Ala54Pro | missense_variant | 1/7 | 1 | NM_003927.5 | ENSP00000256429 | P1 | |
MBD2 | ENST00000583046.1 | c.160G>C | p.Ala54Pro | missense_variant | 1/3 | 1 | ENSP00000464554 | |||
MBD2 | ENST00000398398.6 | c.160G>C | p.Ala54Pro | missense_variant | 1/3 | 2 | ENSP00000381435 |
Frequencies
GnomAD3 genomes AF: 0.0000134 AC: 2AN: 149116Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000605 AC: 1AN: 16520Hom.: 0 AF XY: 0.000105 AC XY: 1AN XY: 9558
GnomAD4 exome AF: 0.0000227 AC: 25AN: 1101912Hom.: 0 Cov.: 31 AF XY: 0.0000283 AC XY: 15AN XY: 530786
GnomAD4 genome AF: 0.0000134 AC: 2AN: 149204Hom.: 0 Cov.: 32 AF XY: 0.0000137 AC XY: 1AN XY: 72824
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 11, 2022 | The c.160G>C (p.A54P) alteration is located in exon 1 (coding exon 1) of the MBD2 gene. This alteration results from a G to C substitution at nucleotide position 160, causing the alanine (A) at amino acid position 54 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at